Advertisement
Screener

ABSCI CORP (ABSI) Graph

ABSI Revenue Flow

Filed revenue amounts for 2026-04-01 to 2026-06-30. Coverage is partial. Unconnected amounts are separate disclosures; they must not be added together.

  • 2026-06-30: Revenue (m); Revenue including tax $318.00K; Research and development $22.62M; Selling, general and administrative $9.16M.
  • 2026-03-31: Revenue (m); Revenue including tax $215.00K; Research and development $19.27M; Selling, general and administrative $9.06M.
  • 2025-12-31: Revenue (m); Revenue including tax $650.00K*; Research and development $25.35M*; Selling, general and administrative $8.62M*.
  • 2025-09-30: Revenue (m); Revenue including tax $378.00K; Research and development $19.25M; Selling, general and administrative $8.44M.

Revenue flow

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

ABSI revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.Revenue$318.00KOperating expenses$34.48MOperating income-$34.16MOther income, net$990.00KResearch & development$22.62MSelling, general& administrative$9.16MPre-tax income-$33.17MIncome tax$40.00KNet income-$33.21M

Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.

Historical revenue and expense breakdown

Revenue and expense 3 month

Period endRevenueRevenue including taxResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2026-06-30(m)$318.00K$22.62M$9.16M$34.48M$40.00K-$33.21M
2026-03-31(m)$215.00K$19.27M$9.06M$31.06M$18.00K-$29.60M
2025-12-31(m)$650.00K*$25.35M*$8.62M*$31.69M*-$162.00K*-$29.56M*
2025-09-30(m)$378.00K$19.25M$8.44M$30.53M$104.00K-$28.71M
2025-06-30(m)$593.00K$20.46M$8.53M$31.99M$131.00K-$30.57M
2025-03-31(m)$1.18M$16.36M$9.47M$28.91M-$4.00K-$26.35M
2024-12-31$665.00K*(m)(m)(m)(m)(m)(m)
2024-09-30$1.70M$1.70M$17.98M$9.26M$30.60M$37.00K-$27.40M
2024-06-30$1.27M$1.27M$15.26M$9.35M$27.99M$0.00-$24.75M
2024-03-31$898.00K$898.00K$12.24M$8.74M$24.40M$12.00K-$21.98M
2023-09-30$744.00K$744.00K$11.03M$9.51M$24.05M$34.00K-$21.99M
2023-06-30$3.37M$3.37M$12.11M$9.41M$46.35M$11.00K-$41.67M
2023-03-31$1.27M$1.27M$12.66M$9.59M$25.75M$7.00K-$23.36M
2022-09-30$2.37M$2.00M$15.53M$11.41M$30.34M-$312.00K-$27.26M
2022-06-30$1.00M$636.00K$16.24M$10.51M$29.89M-$270.00K-$28.68M
2022-03-31$819.00K$454.00K$15.83M$10.89M$29.62M$621.00K-$29.49M
2021-09-30$1.54M$1.39M$10.73M$9.73M$22.68M-$1.70M-$23.63M
2021-06-30$728.00K$592.00K$11.04M$5.18M$17.42M-$5.62M-$41.20M
2021-03-31$1.06M$940.00K$7.05M$4.68M$12.21M-$477.00K-$10.96M
2020-09-30$916.00K$922.00K$2.69M$1.26M$4.28M$0.00-$3.75M
2020-06-30$564.00K(m)$2.25M$861.00K$3.38M$0.00-$3.01M
2020-03-31(m)(m)(m)(m)(m)(m)-$2.66M

Revenue and expense 6 month

Period endRevenueRevenue including taxResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2026-06-30(m)$533.00K$41.89M$18.22M$65.54M$58.00K-$62.81M
2025-06-30(m)$1.77M$36.82M$18.00M$60.89M$127.00K-$56.91M
2024-06-30$2.17M$2.17M$27.50M$18.09M$52.39M$12.00K-$46.73M
2023-06-30$4.64M$4.64M$24.77M$19.00M$72.11M$18.00K-$65.03M
2022-06-30$1.82M$1.09M$32.07M$21.40M$59.51M$351.00K-$58.17M
2021-06-30$1.79M$1.53M$18.09M$9.86M$29.63M-$6.09M-$52.16M
2020-06-30$1.14M(m)$4.16M$1.83M$6.44M$0.00-$5.67M

Revenue and expense 9 month

Period endRevenueRevenue including taxResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2025-09-30(m)$2.15M$56.07M$26.44M$91.43M$231.00K-$85.62M
2024-09-30$3.87M$3.87M$45.48M$27.35M$82.98M$49.00K-$74.12M
2023-09-30$5.38M$5.38M$35.80M$28.51M$96.16M$52.00K-$87.02M
2022-09-30$4.19M$3.09M$47.59M$32.80M$89.85M$39.00K-$85.43M
2021-09-30$3.33M$2.92M$28.82M$19.60M$52.31M-$7.80M-$75.79M
2020-09-30$2.05M$1.96M$6.85M$3.09M$10.72M$0.00-$9.41M

Revenue and expense 12 month

Period endRevenueRevenue including taxResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2025-12-31(m)$2.80M$81.42M$35.06M$123.12M$69.00K-$115.18M
2024-12-31$4.53M$4.53M$63.86M$36.17M$113.42M$70.00K-$103.11M
2023-12-31$5.72M$5.72M$48.07M$37.83M$121.23M$100.00K-$110.57M
2022-12-31$5.75M$4.53M$58.91M$40.55M$112.50M-$461.00K-$104.90M
2021-12-31$4.78M$4.01M$44.59M$28.78M$80.02M-$8.90M-$100.96M
2020-12-31$4.78M$4.12M$11.45M$5.50M$18.08M$0.00-$14.35M

Similar stocks

Stock NameCountryMarket CapPE Ratio
OmniAb, Inc. (OABI)United States$0.698B-8.05
NRC HEALTH (NRC)United States$0.450B42.50
MAXCYTE, INC. (MXCT)United States$0.124B-3.68
bioAffinity Technologies, Inc. (BIAF)United States$0.063B
OneMedNet Corp (ONMD)$0.042B
iSpecimen Inc. (ISPC)United States$0.003B
FOXO TECHNOLOGIES INC. (FOXO)United States$0.000B-277.71
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)United States$14.060B-43.97
Medpace Holdings, Inc. (MEDP)United States$17.316B30.09
INCYTE CORP (INCY)United States$24.855B13.14